Michael J. McElhaugh

Interim President & CEO at Arbutus Biopharma Corporation

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2024

3 years of board service in total across 1 board, counting each seat separately. Longest: Arbutus Biopharma Corporation, 2 years.

Arbutus Biopharma Corporation Director · Interim President & CEO
2 years · Since 2024

Chief executive roles

Arbutus Biopharma Corporation · Interim President & CEO Interim
Until February 2025 · Former

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Feb 14, 2025 Arbutus Biopharma Corporation Grant or award +177,000 — —
Feb 4, 2025 Arbutus Biopharma Corporation Open-market sale −23,790 $3.28 $78,031
Feb 2, 2024 Arbutus Biopharma Corporation Open-market sale −10,164 $2.31 $23,479
Feb 1, 2024 Arbutus Biopharma Corporation Grant or award +123,800 — —

Questions about Michael J. McElhaugh

What boards is Michael J. McElhaugh on?

Michael J. McElhaugh sits on the board of Arbutus Biopharma Corporation.

Has Michael J. McElhaugh been a CEO?

Yes — Michael J. McElhaugh was CEO of Arbutus Biopharma Corporation (Until February 2025).

How long has Michael J. McElhaugh served on boards?

Our records show at least 3 years of board service across 1 board, the earliest from 2024.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.